ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
0.257
-0.020 (-7.09%)
At close: Nov 4, 2024, 4:00 PM
0.253
-0.004 (-1.44%)
After-hours: Nov 4, 2024, 7:59 PM EST
ENDRA Life Sciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
4.78M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
IM Cannabis | 36.45M |
Nuwellis | 9.01M |
Evoke Pharma | 7.53M |
Silo Pharma | 72.10K |
Creative Medical Technology Holdings | 17.00K |
NDRA News
- 13 days ago - ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany - Business Wire
- 2 months ago - Data I/O And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
- 2 months ago - ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements - Business Wire
- 2 months ago - ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update - Business Wire
- 2 months ago - ENDRA Life Sciences Announces Reverse Stock Split - Business Wire
- 2 months ago - ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024 - Business Wire
- 2 months ago - ENDRA Life Sciences Announces Leadership Changes - Business Wire